Skip to main content
GYRE logo

GYRE · Gyre Therapeutics, Inc.

Track GYRE — free
$6.86 +0.42 (+6.52%) At close · Sep 4
Market Cap
$714.78M
Shares
111.51M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

GYRE Latest Reported Short Interest

FINRA reported 1,745,865 GYRE shares sold short as of the August 14, 2026 settlement date, a decrease of 77,855 shares. Days to cover was 31.05 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

GYRE Short Interest Forecast

Equibles' model estimates 1,722,260 shares sold short for the August 31, 2026 settlement, -1.4% versus the latest reported position, with a likely range of 1,552,039 to 1,852,537 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 31 High confidence 70% chance it falls
1,722,260 -1.4% vs reported
Likely range 1,552,039 to 1,852,537 The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
61/100
Short interest 1.6% of shares — P45 Days to cover 31.1 — P97 Price vs VWAP +0.9% — P58 Short-volume trend +6.8% — P74 Short interest change -4.3% — P38 Worst FTD 0.00% of shares — P40

Peer-relative percentile rank across all listed securities reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 1,745,865 1,823,720 -77,855 31.05
2026-07-31 1,823,720 2,043,169 -219,449 37.39
2026-07-15 2,043,169 1,826,634 +216,535 24.18
2026-06-30 1,826,634 1,740,077 +86,557 11.78
2026-06-15 1,740,077 1,672,318 +67,759 18.43
2026-05-29 1,672,318 1,675,711 -3,393 17.64
2026-05-15 1,675,711 1,580,423 +95,288 18.17
2026-04-30 1,580,423 1,584,269 -3,846 32.58
2026-04-15 1,584,269 1,525,798 +58,471 25.93
2026-03-31 1,525,798 1,377,210 +148,588 10.82
2026-03-13 1,377,210 1,344,228 +32,982 8.36
2026-02-27 1,344,228 1,482,748 -138,520 18.56
2026-02-13 1,482,748 1,420,459 +62,289 27.89
2026-01-30 1,420,459 1,494,183 -73,724 18.46
2026-01-15 1,494,183 1,377,062 +117,121 17.65
2025-12-31 1,377,062 1,384,238 -7,176 13.05
2025-12-15 1,384,238 1,470,729 -86,491 19.52
2025-11-28 1,470,729 1,476,320 -5,591 27.75
2025-11-14 1,476,320 1,540,111 -63,791 26.45
2025-10-31 1,540,111 1,502,320 +37,791 22.96
2025-10-15 1,502,320 1,670,982 -168,662 14.93
2025-09-30 1,670,982 1,618,588 +52,394 16.17
2025-09-15 1,618,588 1,739,858 -121,270 16.00

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1124105 CUSIP 403783103 13F (30d) 45 filings 45 filers Visit website Investor relations